Trigyn Technologies Limited has informed the Exchange about General Updates
TRIGYN · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Trigyn Technologies has received in-principle approval from both NSE and BSE to list up to 4,50,000 equity shares of Rs. 10 each under its Employee Stock Option Plan 2025. These shares will be allotted to employees as and when they exercise their stock options, subject to SEBI's Share Based Employee Benefits Regulations. The company still needs to complete post-allotment formalities and regulatory compliances before the shares are actually listed and traded. The total potential dilution is around Rs. 4.5 crore in face value terms.
Existing shareholders may face minor dilution of up to 4,50,000 shares once employees begin exercising their stock options, though the size is small relative to typical share counts. This is a routine ESOP-related approval and is generally neutral to mildly positive as it signals the company is retaining and incentivizing employees.